Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000093751-25-000280·Intellia Therapeutics, Inc.
Schedule 13G ownership disclosure
Intellia Therapeutics Inc
COMMON STOCK · CUSIP: 45826J105
Event date: 2025-03-31
- Filing-level shares
- 4,510,261.00
- Percent of class
- 4.4%
- STATE STREET CORPORATION
Shares: 4,510,261.00 · Class: 4.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-25-000280
- Form type
- SCHEDULE 13G
- Filer
- Intellia Therapeutics, Inc.
- CIK
- CIK 1652130
- Filed
- May 13, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership